These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34331472)

  • 1. Impurity profiling and stability-indicating method development and validation for the estimation of assay and degradation impurities of midostaurin in softgel capsules using HPLC and LC-MS.
    Lakka NS; Kuppan C; Ravinathan P
    Biomed Chromatogr; 2021 Dec; 35(12):e5222. PubMed ID: 34331472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N; Sangeetha D; Reddy SP
    J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation pathways and impurity profiling of the anticancer drug apalutamide by HPLC and LC-MS/MS and separation of impurities using Design of Experiments.
    Lakka NS; Kuppan C; Vadagam N; Reddamoni SY; Muthusamy C
    Biomed Chromatogr; 2023 Feb; 37(2):e5549. PubMed ID: 36409057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of novel RP-HPLC method for midostaurin determination using analytical quality by design approach from regulatory perspective and determination of major degradation compounds of midostaurin using LC-MS.
    Reddy Saddala MP; Konduru N; Gundla R; Kowtharapu LP
    Biomed Chromatogr; 2022 Dec; 36(12):e5486. PubMed ID: 36001450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability Indicating RP-HPLC Method for Estimation of Potential Impurities in Ledipasvir and Characterization of a New Degradation Impurity.
    Siva Kumar R; Sravan Kumar KV; Kondareddy L; Yogeshwara KR; Manish G; Jeenet J; Nitesh K
    J Chromatogr Sci; 2018 May; 56(5):383-395. PubMed ID: 29474520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability-indicating method development and validation for quantitative estimation of assay and organic impurities of antiviral drug baloxavir marboxil in drug substance and pharmaceutical dosage form using HPLC and LC-MS methods.
    Nagulancha BR; Lakka NS; Vandavasi KR
    Biomed Chromatogr; 2023 Aug; 37(8):e5644. PubMed ID: 37052118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Elucidation of Novel Degradation Impurity and Development, Validation of a Single HPLC Method for all Putative Impurities of Clobetasol Propionate in a Foam Drug Product.
    Ketha NVDP; Kolli D; Subbappa PK
    J Chromatogr Sci; 2024 May; 62(5):444-453. PubMed ID: 36857571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability-indicating liquid chromatography method development and validation for impurity profiling of montelukast sodium in bulk drug and tablet dosage form.
    Pasham M; Haridasyam SB; Boppy NVVDP; Venkatanarayana M; Palakurthi AK
    Biomed Chromatogr; 2022 Apr; 36(4):e5330. PubMed ID: 34994006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPLC method development, validation, and impurity characterization of a potent antitumor indenoisoquinoline, LMP776 (NSC 725776).
    Wang J; Liu M; Yang C; Wu X; Wang E; Liu P
    J Pharm Biomed Anal; 2016 May; 124():267-273. PubMed ID: 26970596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RP-LC Method Development and Validation for Dasatinib Forced Degradation Study: Isolation and Structural Characterization by NMR and HRMS.
    Kavitapu DR; Murty JNSRC; Maruthapillai A; Senadi GC; Mahapatra S
    J Chromatogr Sci; 2024 Apr; 62(4):347-355. PubMed ID: 37340779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an efficient stability-indicating LC-MS/MS method for the analysis of selexipag and characterization of its degradation products.
    Amara Babu NLA; Koganti K; Palakeeti B; Srinivas KSV; Rao KP
    Biomed Chromatogr; 2021 Oct; 35(10):e5178. PubMed ID: 33998014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Stability-Indicating Purity Method for Ubrogepant Through Stress Degradation Analysis, Extraction, and Characterization of Unidentified Degradation Products Using Flash Chromatography, NMR, IR, and LC-MS.
    Vanga NR; K VR; Ummiti K; Ratnakaram VN
    J AOAC Int; 2024 Oct; 107(5):761-773. PubMed ID: 38941508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a stability-indicating HPLC method of etifoxine with characterization of degradation products by LC-MS/TOF, 1H and 13C NMR.
    Djabrouhou N; Guermouche MH
    J Pharm Biomed Anal; 2014 Nov; 100():11-20. PubMed ID: 25117950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability-indicating HPLC method for quantification of celecoxib and diacerein along with its impurities in capsule dosage form.
    Bapatu HR; Maram RK; Murthy RS
    J Chromatogr Sci; 2015 Jan; 53(1):144-53. PubMed ID: 24837233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability-indicating HPLC method for simultaneous quantification of 14 impurities in excedrin tablet formulations and identification of new impurity by LC-MS in accelerated stability studies.
    Dongala T; Katari NK; Palakurthi AK; Jonnalagadda SB
    Biomed Chromatogr; 2019 Oct; 33(10):e4608. PubMed ID: 31145484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical method development and validation for the analysis of verapamil hydrochloride and its related substances by using ultra perfomance liquid chromatography.
    Vijayabaskar S; Mahalingam V; Kalaivani
    J Pharm Biomed Anal; 2017 Apr; 137():189-195. PubMed ID: 28131058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability-indicating HPLC method development and validation of rivaroxaban impurities and identification of forced degradation products using LC-MS/MS.
    Cholleti V; Ravindra Kumar Y; Pasula A; Surya PRP
    Biomed Chromatogr; 2022 Sep; 36(9):e5424. PubMed ID: 35697473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.